Blood Transfusion by Boston MedFlight Registry

Status unconfirmed

Conditions studied: Hemorrhagic Shock

In brief

The primary aim of this observational registry is to study the outcomes of patients with hemorrhagic shock transported by Boston MedFlight receiving blood products during transport.

Key facts

Study ID

NCT04610814

Run by

Massachusetts General Hospital

People needed

500

Starts

2019-11-01

Expected to finish

2024-12-01

Last updated by the study team

2021-09-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients who would be eligible to receive blood products;
• systolic blood pressure <90 mmHg
• a shock index of > 0.9
• clinical signs of shock as determined by the transport clinicians.

You may not qualify if…

• Age < 18 years old

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.